ClinicalTrials.gg
Drug

Oseltamivir clinical trials

Also written Tamiflu.

studies test it
90
open now
4
in phase 3
15
first study started
2001

How each study uses Oseltamivir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Oseltamivir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Oct 1999 · TAMIFLU · NDA 021087 (FDA, Drugs@FDA)
European Union
20 Jun 2002 · Tamiflu · EMEA/H/C/000402 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Oseltamivir
60
oseltamivir [Tamiflu]
4
Oseltamivir Phosphate
3
Oseltamivir 75 mg
2
oseltamivir (Tamiflu®)
2

Brand

Tamiflu
37

Development codes

HEC116094
1
HIP1403
1

In one entry with another drug

Given together, or one or the other

oseltamivir + zanamivir
2

Studies by the year they started

90 studies that test it; most in 2009 (15)

Studies that test Oseltamivir, by start year
YearStudies
20011
20051
20065
20075
20086
200915
201011
20115
20124
20133
20144
20155
20163
20182
20191
20208
20214
20234
20253

By phase

A phase 1/2 study counts in both.

Phase 1
30
Phase 2
18
Phase 3
15
Phase 4
25
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 37 · Other 53

Hoffmann-La Roche (16) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · University of Oxford (5) · Capital Medical University (4) · Tongji Hospital (4) · Chinese University of Hong Kong (3) · GlaxoSmithKline (3) · MedImmune LLC (2)

Often tested with

Tested in the same studies.

Zanamivir (6) · Pimodivir (3) · Peramivir (3) · Amantadine (3) · Baloxavir (3) · Hydroxychloroquine (2) · Azithromycin (2) · MEDI8852 (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Oseltamivir, phase 3 first.

Studies

Open first, then newest update. How each study uses Oseltamivir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 90

See all 90 studies that test Oseltamivir →

Given beside what is tested · 16 — Oseltamivir is usual care or a partner of the new treatment
As the comparator · 22 — what is tested is compared with Oseltamivir

Showing 20 of 22.

Codes

What other systems call Oseltamivir · ClinicalTrials.gg INT008880

  • MeSH (NLM) D053139OseltamivirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 20O93L6F9HOSELTAMIVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 260101Confirmed FDA, Wikidata
  • Wikidata Q211509oseltamivirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62061OseltamivirOne source FDA
  • DrugBank DB00198One source Wikidata

Also registered as oseltamivir phosphate (UNII 4A3O49NGEZ · RxNorm 259275).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.